Breast cancer is the most diagnosed malignancy among women worldwide. When detected at Stage 0 or Stage 1, the 5-year survival rate exceeds 95%. Routine periodic screening represents every woman’s strongest shield against breast diseases.
Clinical Components of Breast Screening
- Specialized Clinical Breast Palpation: Thorough anatomical evaluation of bilateral breast quadrants, axillary tail, and supraclavicular lymph node chains by experienced clinicians.
- High-Resolution Breast Ultrasonography: High-frequency linear transducer sonography offering exceptional spatial resolution to distinguish between benign cystic structures and solid suspicious masses.
- ACR BI-RADS Categorization: Standardized radiological reporting (BI-RADS 1 to 5) ensuring unambiguous clinical recommendations and structured follow-up timelines.
- Diagnostic Coordination: Immediate coordination for ultrasound-guided core needle or fine-needle aspiration biopsy when suspicious microcalcifications or irregular lesions are identified.
